OPX Biotechnologies closes $12 million series C funding for microbe modification technology for advanced biofuels

In Colorado, Boulder, genomic search company OPX Biotechnologies is reported to have closed a $12.1 million series C financing round, the first cleantech venture capital round reported this month with a strong connection to biofuels. OPX is a licensee of technology from the University of Colorado that optimizes the process of selecting and modifying microbes used in the production of renewable fuels.

The company said it aims to raise an additional $2.9 million for the expansion of staff and increase the pace of engineering activity. The company is backed by Braemar Energy Ventures, Mohr Davidow Ventures and X/Seed Capital.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

OPX Biotechnologies raises $17.5 million in third round of funding for bioacrylic, biodiesel microbe-based technology

In Colorado, OPX Biotechnologies announced that it has raised $17.5 million in third round funding from Braemar Energy Ventures, Altira Group, X/Seed Capital and Mohr Davidow Ventures for its technolo...

Amyris Technolgies closes $70 million in second-round financing to pursue new biofuel conversion technologies

In California, Amyris Biotechnologies has closed the first tranche of its $70 million Series B funding led by DAG Ventures and joined by Khosla Ventures, Kleiner Perkins Caufiled & Byers and TPG Ventu...

Sun Ethanol changes name to Qteros, closes $25 million in Series B funding from Rockefellers, Soros, Battery Ventures, others

In Massachusetts, SunEthanol announced that it was changing its name to Qteros and that it had closed a $25 million Series B round of financing, led by venture capital firms Venrock (the Rockefeller f...

Draper Fisher Jurvetson lead $5 million Series A financing round in Glycos Biotechnologies; converting low-value, low-purity carbon sources drop in renewable chemicals

In Texas, Draper Fisher Jurvetson and DFJ Mercury announced that they have led and close a $5.0 million series A investment round in Glycos Biotechnologies. Glycos is using microbes and fermentation t...

Algae pioneer Solix closes $16.8 million Series A financing with new Chinese investor

In Colorado, algae photobioreactor pioneer Solix Biofuels announced the completion of its $16.8 million Series A capital funding that added Shanghai Alliance Investment to its group. Proceeds will be ...

Ze-gen raises $20 million in Series B funding for waste-to-syngas technology

In Massachusetts, Ze-gen announced that it has raised $20 million in Series B funding from Omaz Zawawi Establishment, Flagship Ventures, VantagePoint Venture Partners and the Massachusetts Technology ...